Plasminogen activator(human tissue-type 2-chain form), 84-L-serine-, cyclic (6®36),(34®43),(51®73),(56®62),(75®83),(92®173),(113®155),(144®168),(180®261),(201®243),(232®256)-undecakis(disulfide), cyclic(32'®48'),(40'®109'),(134'®209),(166'®182'),(199'®227')-pentakis(disulfide), cyclic(264®120')-disulfide (156616-23-8)

Other Product

• Echistatin a1 (reduced), cyclic (2®11),(7®32),(8®37),(20®39)-tetrakis(disulfide)(9CI)
• 1-223-Colony-stimulatingfactor 1 (human clone p3ACSF-69 protein moiety), cyclic (7®90),(48®139),(102®146)-tris(disulfide), bimol.cyclic (31®31'),(157®157'),(159®159')-tris(disulfide)
• Interleukin 6 (humanclone HGF15 protein moiety reduced), 1-(1-L-alanyl-L-proline)-, cyclic (44®50),(73®83)-bis(disulfide) (9CI)
• Guanylin (humanreduced), cyclic (4®12),(7®15)-bis(disulfide) (9CI)
• Dowex®
• L-Valine,N-(2-quinoxalinylcarbonyl)-L-seryl-L-alanyl-L-cysteinyl-, bimol. (4®1'),(4'®1)-dilactone, cyclic (3®3')-disulfide (9CI)
• L-Valine,N-(2-quinoxalinylcarbonyl)-D-seryl-L-alanyl-N-methyl-L-cysteinyl-, (4®1'),(4'®1)-dilactone, cyclic (3®3')-disulfide (9CI)
• L-Valine,N-9-acridinyl-D-seryl-L-alanyl-L-cysteinyl-, bimol. (4®1'),(4'®1)-dilactone, cyclic (3®3')-disulfide (9CI)
• Neuropeptide F 1(Locusta migratoria reduced), bimol. cyclic (1®6'),(6®1')-bis(disulfide) (9CI)
• Kallidin, cyclic (10®2)-peptide (9CI)
• 2':6®
• 2':6®
• 2:6®
• 2':6®
• 2:6®
• 2:6®
• 2:6®
• D-Valinamide,L-tyrosyl-D-cysteinyl-L-phenylalanyl-3-mercapto-, cyclic (2®4)-disulfide (9CI)
• D-Cysteinamide,L-tyrosyl-D-cysteinylglycyl-L-phenylalanyl-, cyclic (2®5)-disulfide
• Cyclo(D-cysteinyl-D-cysteinyl-L-valyl-D-leucyl-L-leucyl),cyclic (1®2)-disulfide